Detalhe da pesquisa
1.
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial.
Invest New Drugs
; 38(2): 507-514, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036491
2.
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 16(4): 436-46, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795409
3.
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.
Int J Cancer
; 135(8): 1961-9, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24604288
4.
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.
BMC Cancer
; 13: 42, 2013 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23368410
5.
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.
Breast Cancer Res Treat
; 124(3): 733-43, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20882405
6.
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.
Breast Cancer Res Treat
; 123(2): 597-605, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20306128
7.
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
Int J Radiat Oncol Biol Phys
; 68(1): 59-65, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17321065
8.
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Clin Cancer Res
; 12(8): 2468-75, 2006 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16638854
9.
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.
Cancer Res
; 64(1): 286-91, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14729636
10.
Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer.
J Clin Oncol
; 21(5): 851-4, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12610184
11.
Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?
Breast Cancer Res
; 12 Suppl 4: S14, 2010 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21172076
12.
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Clin Cancer Res
; 10(16): 5367-74, 2004 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15328174
13.
Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial.
PLoS One
; 10(7): e0133133, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26186012
14.
Radiation impact in breast cancer.
Breast Cancer Res
; 11 Suppl 3: S14, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20030865
15.
The SUVmax for (18)F-FDG correlates with molecular subtype and survival of previously untreated metastatic breast cancer.
Clin Nucl Med
; 38(4): 256-62, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23429396
16.
Dose density by any other name.
J Clin Oncol
; 22(4): 750-1; author reply 751-3, 2004 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14966105
17.
Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.
J Clin Oncol
; 21(23): 4465; author reply 4465-6, 2003 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14645445
18.
Adjuvant targeted therapy in early breast cancer.
Cancer
; 115(6): 1154-68, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19165856
19.
Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
J Natl Cancer Inst
; 97(2): 116-26, 2005 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-15657341
20.
Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Columbia.
Breast J
; 10(1): 38-44, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-14717758